ask="0.960"
ask_size="600"
average_daily_volume="847952"
bid="0.928"
bid_size="1000"
book_value="0.606"
change="+0.035"
change_from_200_day_moving_average="-0.968"
change_from_50_day_moving_average="-0.047"
change_from_52_week_high="-3.985"
change_From_52_week_low="0.445"
change_in_percent="+3.846%"
close="0.945"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.237"
ebitda="-8.78M"
eps_estimate_current_year="-1.120"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="-0.320"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.960"
high_52_weeks="4.930"
last_trade_date="3/8/2017"
last_trade_price="0.945"
last_trade_size="331"
last_trade_time="4:00pm"
low="0.900"
low_52_weeks="0.500"
market_capitalization="6.75M"
moving_average_200_day="1.913"
moving_average_50_day="0.992"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.330"
open="0.930"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-50.597%"
percent_change_from_50_day_moving_average="-4.765%"
percent_change_from_52_week_high="-80.831%"
percent_change_from_52_week_low="+89.000%"
previous_close="0.910"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.502"
price_per_sales="2.542"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="1.060"
stock_exchange="NCM"
symbol="OPXA"
volume="110687"
weeks_range_52="0.500 - 4.930"
